Join the BioNap Email List!

Wednesday, December 16, 2015

My Interview with Life Science Report

In early December 2015, I was interviewed by George S. Mack of The Life Science Report. I discussed a number of topics during the interview, including biotech equity financings, the use of debt as a financing vehicle, how to position your portfolio for the most upside, and what to do when your investment fails. I also mentioned several names, including Can-Fite, Immune Pharma, RedHill Biopharma, Actinium, Biota, Rexahn, and BriaCell Therapeutics.

That interview was published on December 16, 2015, and can be accessed by the link below.


  1. Hi, I want to thank you for your great posts, they are hugely informative.
    I see your interest in Briacell. Do you see any other biotech on the Canadian side of the border that interests you? The pool to pick from seems rather small.

    1. Yes, I like CYNA (CTH.TO), NRI.TO, and currently doing some work on RVV.V.